Introduction
T h e p53 tumour suppressor protein is a key element in the cell's defence against tumour development, and as such is the focus of considerable study for the development of anticancer therapies (for recent reviews see [1, 2] ). p53 is a potent transcription factor, which is activated in response to signals arising from DNA damage, viral infection, cytokines, hypoxia, activated oncogenes and metabolic changes [3, 4] . Induction of p53 occurs, at least in part, by a post-translational mechanism leading to stabilization of the normally rapidly degraded protein.
Activation of p53 can lead to cell growth arrest at the GJS boundary or the induction of apoptosis (depending on the cell type and presence of survival factors) and is thought to prevent the proliferation of genetically damaged cells. Loss of p53 suppressor function through mutation is a common event in the development of a wide variety of human cancers and may contribute to an increase in the number of genetic abnormalities.
p53 transactivates a wide variety of promoters including WAF1 which promotes Gl/S arrest through inhibition of cyclin-dependent kinases, Mdm 2, which is involved in a negative feedback loop controlling p53 expression, and Bax, which promotes apoptosis. p53 can also repress a wide range of cellular and viral promoters including Bcl-2. Additional functions of p53 include non-specific DNA binding, RNA annealing, DNA association, recognition of damaged DNA and participation in repair processes through its interaction with RAD51 and TFIIH ([1,2] and references therein).
Phosphorylation of p53
T h e pleiotropic nature of p53 and the potency of its effects require it to be tightly regulated in the We have recently concentrated on the potential role of stress-and/or DNA damage-inducible protein kinases in regulating p53 function. In this report, we explore the phosphorylation of p53 by members of the JNK and CK1 families of protein kinases.
Phosphorylation of p53 by JNK
The JNKs are a subset of the MAP kinase superfamily [13] which also comprises the extracellular-regulated kinases (ERKs) and the p38 SAP kinases. JNKs are activated by a cascade mechanism in a manner analogous to the E R G , but unlike the ERKs, the initiating signals for JNKs include cytokines, neurotransmitters, heat shock and W radiation, but not growth factors [14, 15] . JNKs are also activated by ionizing radiation through a separate pathway requiring the c-Abl tyrosine kinase [16] . Murine p53 is phos- W irradiation of SV3T3 cells leads to increased phosphorylation of p53, solely at Ser-34, indicating that p53 is phosphorylated selectively in response to this type of DNA-damage-inducing stress [9] . However, the effect of phosphorylation by JNK on p53 activity is still unclear.
Phosphorylation of p53 by CKI
T h e most highly phosphorylated sites in p53 lie within the first 15 amino acids of the protein [5];
we have shown that these sites are turned over rapidly, consistent with a role in regulation (D. W. Meek and L. McKendrick, unpublished work). Three of these sites, Ser-4, -6 and -9, can be phosphorylated in vitro by CKla (the major isoform of the CK1 family) and by a p53 Nterminus-targeted protein kinase (p53NK) partially purified from 3T3 cell extracts [6]; p53NK has the properties of CKl but can be separated from CKla by affinity chromatography [6] . The significance of the phosphorylation of p53 by CK1 is not yet clear. However, studies with yeast systems have suggested that members of the CK1 family may be involved in DNA repair. For example, the hw2.5 gene encodes a CK1 -related kinase which is an essential component of the DNA-repair process in Sacchammnyces cerevisiae [17] . In addition, two genes sharing significant sequence identity with CK1 were found in Saccharoniyces pontbe [ 181; these genes confer resistance to y-radiation and methylmethanesulphonate but not to UV radiation. Significantly, the 6 isoform of mammalian CK1, but not the a isoform, can complement an hw2.5 deletion mutant in yeast [19] . Therefore there is a potentially striking link between members of a family of kinases involved in DNA repair and p53, a protein that responds to DNA damage.
T o investigate p53NK further, we have characterized its activity in a range of cell lines, after fractionation of cell lysates by ion-exchange chromatography on HiTrap Q and Mono Q resins. Three peaks of p53NK activity can be resolved in HeLa cell lysates, each of which is able to catalyse phosphorylation of up to three residues (Ser-4, -6 and -9 in murine p53) within the N-terminus of the p53 protein. We have also is in a mutant conformation and is located predominantly in the cytoplasm at 38"C, whereas at 32°C or below it is in the wild-type conformation and is nuclear ([ZO] and references therein).} Strikingly, when these cells are shifted from 38 to 28"C, a fivefold stimulation of kinase activity is observed [20] . Moreover, when the DNAdamage-inducing drugs etoposide and camptothecin are added to the cells, a further stimulation of kinase activity can be seen after growth at 28"C, but not at 38°C [ZO] . These data are consistent with a regulatory model in which p53 is sensitive to stress or DNA damage through phosphorylation at its N-terminus. In this model, increased levels of the kinase arise through the transactivation function of p53 and its interaction with a putative p53-responsive element on the kinase promoter (Figure 2) . The model is also consistent with the idea that p53 and the kinase may be involved in an autoregulaIn addition to JNK and p53NK, p53 is also phosphorylated within its N-terminus by DNA-PK, at a site different from those phosphorylated by JNK or p53NK [7, 9] . DNA-PK is activated after binding to DNA containing nicks, gaps or double-stranded breaks [21] . Therefore the tory loop.
N-terminus of p53 is targeted by three independent stress-induced signalling systems, and these may play a major role in the ability of p53 to integrate stress signals [3, 4] . The regulation of p53 function by each of these phosphorylation events and the role of their potential interactivity will be a major focus of p53 research over the next few years. 
